111 related articles for article (PubMed ID: 24243597)
21. Identification of chicken cathelicidin-2 core elements involved in antibacterial and immunomodulatory activities.
van Dijk A; Molhoek EM; Veldhuizen EJ; Bokhoven JL; Wagendorp E; Bikker F; Haagsman HP
Mol Immunol; 2009 Aug; 46(13):2465-73. PubMed ID: 19524300
[TBL] [Abstract][Full Text] [Related]
22. Antimicrobial susceptibility patterns of multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii against carbapenems, colistin, and tigecycline.
Somily AM; Absar MM; Arshad MZ; Al Aska AI; Shakoor ZA; Fatani AJ; Siddiqui YM; Murray TS
Saudi Med J; 2012 Jul; 33(7):750-5. PubMed ID: 22821309
[TBL] [Abstract][Full Text] [Related]
23. In vitro postantibiotic effect of colistin on multidrug-resistant Acinetobacter baumannii.
Plachouras D; Giamarellos-Bourboulis EJ; Kentepozidis N; Baziaka F; Karagianni V; Giamarellou H
Diagn Microbiol Infect Dis; 2007 Apr; 57(4):419-22. PubMed ID: 17188449
[TBL] [Abstract][Full Text] [Related]
24. High cell selectivity and low-level antibacterial resistance of designed amphiphilic peptide G(IIKK)(3)I-NH(2).
Chen C; Hu J; Zeng P; Chen Y; Xu H; Lu JR
ACS Appl Mater Interfaces; 2014 Oct; 6(19):16529-36. PubMed ID: 25210781
[TBL] [Abstract][Full Text] [Related]
25. Anti-infective activity of apolipoprotein domain derived peptides in vitro: identification of novel antimicrobial peptides related to apolipoprotein B with anti-HIV activity.
Kelly BA; Harrison I; McKnight A; Dobson CB
BMC Immunol; 2010 Mar; 11():13. PubMed ID: 20298574
[TBL] [Abstract][Full Text] [Related]
26. Antibiograms of multidrug-resistant clinical Acinetobacter baumannii: promising therapeutic options for treatment of infection with colistin-resistant strains.
Li J; Nation RL; Owen RJ; Wong S; Spelman D; Franklin C
Clin Infect Dis; 2007 Sep; 45(5):594-8. PubMed ID: 17682994
[TBL] [Abstract][Full Text] [Related]
27. Colistin hetero-resistance in multidrug-resistant Acinetobacter baumannii clinical isolates from the Western Pacific region in the SENTRY antimicrobial surveillance programme.
Yau W; Owen RJ; Poudyal A; Bell JM; Turnidge JD; Yu HH; Nation RL; Li J
J Infect; 2009 Feb; 58(2):138-44. PubMed ID: 19058855
[TBL] [Abstract][Full Text] [Related]
28. Melatonin as an antibiotic: new insights into the actions of this ubiquitous molecule.
Tekbas OF; Ogur R; Korkmaz A; Kilic A; Reiter RJ
J Pineal Res; 2008 Mar; 44(2):222-6. PubMed ID: 18289175
[TBL] [Abstract][Full Text] [Related]
29. Synergistic activities between carbapenems and other antimicrobial agents against Acinetobacter baumannii including multidrug-resistant and extensively drug-resistant isolates.
Kiratisin P; Apisarnthanarak A; Kaewdaeng S
Int J Antimicrob Agents; 2010 Sep; 36(3):243-6. PubMed ID: 20541913
[TBL] [Abstract][Full Text] [Related]
30. High tigecycline resistance in multidrug-resistant Acinetobacter baumannii.
Navon-Venezia S; Leavitt A; Carmeli Y
J Antimicrob Chemother; 2007 Apr; 59(4):772-4. PubMed ID: 17353223
[TBL] [Abstract][Full Text] [Related]
31. Structure, interactions, and antibacterial activities of MSI-594 derived mutant peptide MSI-594F5A in lipopolysaccharide micelles: role of the helical hairpin conformation in outer-membrane permeabilization.
Domadia PN; Bhunia A; Ramamoorthy A; Bhattacharjya S
J Am Chem Soc; 2010 Dec; 132(51):18417-28. PubMed ID: 21128620
[TBL] [Abstract][Full Text] [Related]
32. Multidrug-resistant genes are associated with an 86-kb island in Acinetobacter baumannii.
Roberts MC
Trends Microbiol; 2006 Sep; 14(9):375-8. PubMed ID: 16876998
[TBL] [Abstract][Full Text] [Related]
33. Colistin resistance of Acinetobacter baumannii: clinical reports, mechanisms and antimicrobial strategies.
Cai Y; Chai D; Wang R; Liang B; Bai N
J Antimicrob Chemother; 2012 Jul; 67(7):1607-15. PubMed ID: 22441575
[TBL] [Abstract][Full Text] [Related]
34. A new recombinant human apolipoprotein E mimetic peptide with high-density lipoprotein binding and function enhancing activity.
Zhao W; Du F; Zhang M; Sun S; Yu H; Fan D
Exp Biol Med (Maywood); 2011 Dec; 236(12):1468-76. PubMed ID: 22087021
[TBL] [Abstract][Full Text] [Related]
35. Heteroresistance to colistin in multidrug-resistant Acinetobacter baumannii.
Li J; Rayner CR; Nation RL; Owen RJ; Spelman D; Tan KE; Liolios L
Antimicrob Agents Chemother; 2006 Sep; 50(9):2946-50. PubMed ID: 16940086
[TBL] [Abstract][Full Text] [Related]
36. Colistin methanesulfonate against multidrug-resistant Acinetobacter baumannii in an in vitro pharmacodynamic model.
Kroeger LA; Hovde LB; Mitropoulos IF; Schafer J; Rotschafer JC
Antimicrob Agents Chemother; 2007 Sep; 51(9):3431-3. PubMed ID: 17576842
[TBL] [Abstract][Full Text] [Related]
37. Antibacterial activity of carbapenem-based combinations againts multidrug-resistant Acinetobacter baumannii.
Pongpech P; Amornnopparattanakul S; Panapakdee S; Fungwithaya S; Nannha P; Dhiraputra C; Leelarasamee A
J Med Assoc Thai; 2010 Feb; 93(2):161-71. PubMed ID: 20301995
[TBL] [Abstract][Full Text] [Related]
38. Antimicrobial susceptibility of extended-spectrum beta-lactamase producers and multidrug-resistant Acinetobacter baumannii throughout the United States and comparative in vitro activity of tigecycline, a new glycylcycline antimicrobial.
Hoban DJ; Bouchillon SK; Dowzicky MJ
Diagn Microbiol Infect Dis; 2007 Apr; 57(4):423-8. PubMed ID: 17403448
[TBL] [Abstract][Full Text] [Related]
39. A novel tetrabranched antimicrobial peptide that neutralizes bacterial lipopolysaccharide and prevents septic shock in vivo.
Pini A; Falciani C; Mantengoli E; Bindi S; Brunetti J; Iozzi S; Rossolini GM; Bracci L
FASEB J; 2010 Apr; 24(4):1015-22. PubMed ID: 19917670
[TBL] [Abstract][Full Text] [Related]
40. Apolipoprotein E-derived peptides ameliorate clinical disability and inflammatory infiltrates into the spinal cord in a murine model of multiple sclerosis.
Li FQ; Sempowski GD; McKenna SE; Laskowitz DT; Colton CA; Vitek MP
J Pharmacol Exp Ther; 2006 Sep; 318(3):956-65. PubMed ID: 16740622
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
